UPDATE: Canaccord Genuity Initiates Coverage on Regeneron Pharmaceuticals on Expected Continued Pipeline Success
April 16, 2014 at 10:00 AM EDT
In a report published Wednesday, Canaccord Genuity analyst John Newman initiated coverage on Regeneron Pharmaceuticals (NASDAQ: REGN) ...